MedPath

Open Pilot Trial of TES for Depression

Phase 2
Completed
Conditions
Major Depression
Interventions
Device: tDCS (Eldith DC-Stimulator (CE certified))
Registration Number
NCT01201148
Lead Sponsor
The University of New South Wales
Brief Summary

This study will investigate whether using oscillating TES (random noise stimulation) or intermittent tDCS will have greater antidepressant effects in depressed subjects, compared to standard tDCS.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
7
Inclusion Criteria
  • Subject meets criteria for a DSM-IV Major Depressive episode.
Exclusion Criteria
  • Diagnosis (as defined by DSM-IV) of: any psychotic disorder (lifetime); bipolar disorder; eating disorder (current or within the past year); obsessive compulsive disorder (lifetime); post-traumatic stress disorder (current or within the past year); mental retardation.
  • Subject has not responded adequately to standard tDCS or is not appropriate for trial of standard tDCS (eg depression too chronic in duration)
  • Total MADRS depression score of 20 or more
  • History of drug or alcohol abuse or dependence (as per DSM-IV criteria) within the last 3 months (except nicotine and caffeine).
  • Inadequate response to ECT in the current episode of depression.
  • Subject is on regular benzodiazepine medication which it is not clinically appropriate to discontinue.
  • Subject requires a rapid clinical response due to inanition, psychosis or high suicide risk.
  • Neurological disorder or insult, e.g., recent stroke (CVA), which places subject at risk of seizure or neuronal damage with TES.
  • Subject has metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash) at proposed electrode sites.
  • Female subject who is pregnant. However, women of child bearing age are eligible if they have the pregnancy test but will be excluded if they are sexually active and not using reliable contraception (urine test for pregnancy will be used if appropriate).

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Oscillating or intermittent tDCStDCS (Eldith DC-Stimulator (CE certified))-
Primary Outcome Measures
NameTimeMethod
Montgomery Asberg Depression Rating Scale for Depression (MADRS)6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Black Dog Institute

🇦🇺

Sydney, New South Wales, Australia

© Copyright 2025. All Rights Reserved by MedPath